|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$119
|
$319B |
4.9x |
10.7x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$202B |
3.3x |
8.2x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£22
|
$138B |
3.1x |
9.2x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$134B |
2.5x |
8.3x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 152
|
$62.3B |
3.7x |
10.9x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€264
|
$60.7B |
6.9x |
22.4x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$41
|
$12.1B |
6.3x |
-3.8x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$106
|
$9.6B |
3.1x |
-7.8x |
|
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$7.6B |
3.6x |
-39.2x |
|
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 213
|
$7.5B |
7.5x |
24.4x |
|
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 40
|
$6.9B |
23.2x |
545.6x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$6.8B |
61.3x |
N/A |
|
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$55
|
$6.3B |
N/A |
-7.4x |
|
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2667
|
$4.8B |
11.2x |
34.2x |
|
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 15
|
$3.5B |
5.2x |
14.0x |
|
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 40
|
$3.0B |
N/A |
N/A |
|
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 12
|
$2.6B |
7.2x |
25.1x |
|
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 15
|
$2.5B |
5.9x |
22.0x |
|
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 8827
|
$2.4B |
N/A |
N/A |
|
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$2.3B |
N/A |
N/A |
|
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 50700
|
$2.3B |
5.2x |
-83.2x |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$2.2B |
283.8x |
-10.5x |
|
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 187
|
$1.9B |
2.0x |
5.4x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$20
|
$1.7B |
7.1x |
-4.8x |
|
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 38
|
$1.6B |
6.4x |
274.9x |
|
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 21
|
$1.5B |
N/A |
N/A |
|
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$19
|
$1.5B |
N/A |
N/A |
|
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 15977
|
$1.5B |
N/A |
N/A |
|
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$55
|
$1.3B |
6.3x |
-47.7x |
|
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$71
|
$1.3B |
29.4x |
-8.5x |
|
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 71
|
$1.2B |
6.5x |
17.6x |
|
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€28
|
$1.2B |
N/A |
N/A |
|
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 20
|
$1.2B |
N/A |
N/A |
|
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 12
|
$1.0B |
N/A |
N/A |
|
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 6
|
$998M |
32.5x |
-27.0x |
|
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$984M |
378.1x |
-3.8x |
|
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$981M |
11.6x |
-29.3x |
|
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$935M |
N/A |
-12.1x |
|
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 16
|
$931M |
5.8x |
12.4x |
|
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$902M |
4.5x |
-17.3x |
|
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$8
|
$856M |
0.8x |
2.3x |
|
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$835M |
17.8x |
-4.2x |
|
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 26
|
$823M |
N/A |
N/A |
|
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$782M |
9.4x |
-72.0x |
|
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 3
|
$681M |
3.6x |
N/A |
|
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$667M |
32.1x |
-1.3x |
|
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 23
|
$583M |
N/A |
N/A |
|
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 471
|
$579M |
N/A |
N/A |
|
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 5
|
$502M |
N/A |
N/A |
|
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$465M |
369.9x |
-1.5x |
|
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$460M |
82.1x |
N/A |
|
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 416
|
$450M |
N/A |
N/A |
|
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$443M |
N/A |
N/A |
|
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 26
|
$422M |
2.2x |
9.3x |
|
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 5
|
$396M |
N/A |
N/A |
|
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$379M |
N/A |
-14.7x |
|
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$352M |
N/A |
N/A |
|
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$349M |
6.9x |
-6.3x |
|
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 36
|
$329M |
N/A |
N/A |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$13
|
$320M |
120.1x |
-2.1x |
|
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 25
|
$315M |
N/A |
N/A |
|
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 18
|
$287M |
N/A |
N/A |
|
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$282M |
25.6x |
-7.2x |
|
Kyverna Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$273M |
N/A |
-1.6x |
|
ALX Oncology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$264M |
N/A |
N/A |
|
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$262M |
11640.9x |
-1.5x |
|
Enlivex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$246M |
N/A |
N/A |
|
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$228M |
N/A |
-5.0x |
|
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$190M |
104569.6x |
-0.9x |
|
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$188M |
65.1x |
-9.7x |
|
Shattuck Labs
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$165M |
137.1x |
-3.4x |
|
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$160M |
4.8x |
N/A |
|
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$145M |
1.1x |
N/A |
|
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$140M |
N/A |
-0.8x |
|
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9840
|
$140M |
N/A |
N/A |
|
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$139M |
N/A |
N/A |
|
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 19
|
$132M |
N/A |
N/A |
|
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€4
|
$116M |
2.3x |
-39.0x |
|
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 26
|
$107M |
N/A |
N/A |
|
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£1
|
$102M |
N/A |
-3.6x |
|
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$1
|
$101M |
N/A |
N/A |
|
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 14
|
$97.9M |
N/A |
N/A |
|
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$92.6M |
N/A |
N/A |
|
Coherus Oncology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$92.0M |
2.1x |
-0.5x |
|
SAB Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$91.7M |
N/A |
N/A |
|
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$80.8M |
N/A |
-3.2x |
|
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$78.2M |
N/A |
N/A |
|
Adagene
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$76.9M |
15.4x |
N/A |
|
TuHURA Biosciences
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$76.4M |
N/A |
N/A |
|
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$73.3M |
9.9x |
N/A |
|
Nykode Therapeutics
|
Norway |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
NOK 4
|
$71.6M |
68.1x |
-2.4x |
|
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$71.1M |
12.0x |
N/A |
|
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$67.8M |
767.2x |
N/A |
|
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$67.7M |
N/A |
N/A |
|
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$67.4M |
N/A |
N/A |
|
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$1
|
$65.7M |
0.9x |
-0.3x |
|
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$58.0M |
N/A |
N/A |
|
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$51.8M |
15.6x |
-1.4x |
|
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$50.9M |
N/A |
N/A |
|
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€5
|
$45.6M |
N/A |
N/A |